VA
CVS icon

Vident Advisory’s CVS Health CVS Stock Holding History

Vident Advisory’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.71M Sell
79,440
-14,601
-16% -$1.12M 0.05% 324
2025
Q4 		$7.46M Buy
94,041
+41,023
+77% +$3.23M 0.07% 239
2025
Q3 		$4M Buy
53,018
+2,313
+5% +$159K 0.04% 364
2025
Q2 		$3.5M Buy
50,705
+31,439
+163% +$2.06M 0.04% 357
2025
Q1 		$1.31M Sell
19,266
-13,967
-42% -$836K 0.02% 626
2024
Q4 		$1.49M Sell
33,233
-48,983
-60% -$2.75M 0.03% 499
2024
Q3 		$5.17M Buy
82,216
+56,750
+223% +$3.31M 0.13% 152
2024
Q2 		$1.5M Sell
25,466
-346,517
-93% -$21.7M 0.04% 462
2024
Q1 		$29.7M Buy
371,983
+48,785
+15% +$3.73M 0.62% 28
2023
Q4 		$25.5M Sell
323,198
-397
-0.1% -$28.3K 0.64% 16
2023
Q3 		$22.6M Buy
+323,595
New +$22.9M 0.7% 16

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Vident Advisory's CVS Position: Q1 2026 in Review

Vident Advisory reduced its CVS Health (CVS) stake by 16% in Q1 2026, selling an estimated $1.12M and leaving 79,440 shares worth $5.71M. The position accounts for 0.05% of the portfolio, ranked #324.

Vident Advisory first reported a position in CVS in Q3 2023 and has held it in 11 quarters since. The position peaked at $29.7M in Q1 2024. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Vident Advisory held 79,440 shares of CVS Health worth $5.71M as of Q1 2026.
  • Vident Advisory sold 14,601 CVS Health shares in Q1 2026, an estimated $1.12M.
  • CVS Health made up 0.05% of Vident Advisory's portfolio in Q1 2026, its #324 holding.
  • Vident Advisory first reported a position in CVS Health in Q3 2023 and has held it in 11 quarters since.
  • Vident Advisory's CVS Health position peaked at $29.7M in Q1 2024.
  • 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.